These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cisternal lavage via third ventriculostomy through the fenestrated lamina terminalis after aneurysm clipping: Technical note. Roelz R; Grauvogel J; Scheiwe C; Shah M; Beck J; Reinacher PC; Hubbe U J Clin Neurosci; 2019 Jun; 64():283-286. PubMed ID: 30922533 [TBL] [Abstract][Full Text] [Related]
11. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage. Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652 [TBL] [Abstract][Full Text] [Related]
12. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial. Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026 [TBL] [Abstract][Full Text] [Related]
13. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711 [TBL] [Abstract][Full Text] [Related]
14. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage. Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M; J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238 [TBL] [Abstract][Full Text] [Related]
15. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage. Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453 [TBL] [Abstract][Full Text] [Related]
16. REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Mayer SA; Bruder N; Citerio G; Defreyne L; Dubois C; Gupta R; Higashida R; Marr A; Nguyen TN; Roux S; Smrčka M; Torné RT; Aldrich EF; J Neurosurg; 2024 Aug; ():1-12. PubMed ID: 39126720 [TBL] [Abstract][Full Text] [Related]
17. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis. Grossen AA; Ernst GL; Bauer AM Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885 [TBL] [Abstract][Full Text] [Related]
18. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage. Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL; Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage. Etminan N; Macdonald RL; Davis C; Burton K; Steiger HJ; Hänggi D Acta Neurochir Suppl; 2015; 120():281-6. PubMed ID: 25366637 [TBL] [Abstract][Full Text] [Related]
20. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan. Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]